Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Egtazic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.87 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.87 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.87 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | EYA2 | O00167 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.54 |
| ▸ | ACE | P12821 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11684972 | 0.93 | BLM (1.00) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL22901 | 0.93 | BLM (1.00) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL920203 | 0.93 | BLM (1.00) | BLMPMP22HSD17B10TDP1EYA2 | |
| SCHEMBL18328810 | 0.92 | BLM (0.80) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL3631773 | 0.91 | BLM (0.87) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL4587716 | 0.91 | BLM (0.87) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL23859106 | 0.91 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL7541607 | 0.91 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL456632 | 0.91 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 | |
| Egtazic Acid SCHEMBL5067266 | 0.91 | BLM (0.95) | BLMPMP22HSD17B10TDP1EYA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020064534-A1 | Herpesvirus preparations and their uses | PHOGEN LIMITED | 2002-05-30 | — | — | US | disclosed |
| US-6342229-B2 | Herpesvirus particles comprising fusion protein and their preparation and use | PHOGEN, LIMITED (GB) | 2002-01-29 | — | — | US | disclosed |
| US-20010048928-A1 | HERPESVIRUS PARTICLES COMPRISING FUSION PROTEIN AND THEIR PREPARATION AND USE | PHOGEN LIMITED (GB) | 2001-12-06 | — | — | US | disclosed |
| EP-1100934-A1 | HERPESVIRUS PREPARATIONS AND THEIR USES | Phogen Limited (GB) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000008182-A1 | HERPESVIRUS PREPARATIONS AND THEIR USES | PHOGEN LIMITED (GB) | 2000-02-17 | — | — | WO | disclosed |